Jean Philippe Bizot Espiard
About Jean Philippe Bizot Espiard
Jean Philippe Bizot Espiard is a Regulatory Affairs Associate at SOPHiA GENETICS in Lausanne, Switzerland, where he has worked since 2021. He has previous experience in regulatory affairs and quality assurance in the medical device sector and holds advanced degrees in biotechnology.
Work at SOPHiA GENETICS
Jean Philippe Bizot Espiard has been serving as a Regulatory Affairs Associate at SOPHiA GENETICS since 2021. Located in Lausanne, Vaud, Switzerland, he has contributed to the company's regulatory compliance efforts for three years. His role involves ensuring that the company's products meet the necessary regulatory standards and facilitating the approval processes for medical devices.
Previous Experience in Regulatory Affairs
Before joining SOPHiA GENETICS, Jean Philippe worked as a RA/QA consultant for IVD medical devices at Amaris from 2020 to 2021 in Eindhoven, Brabant Septentrional, Pays-Bas. He also completed a five-month internship as an Ingénieur d'étude at INSERM, the French National Institute of Health and Medical Research, from 2015 to 2016 in Région de Montpellier, France. These roles provided him with foundational experience in regulatory affairs and quality assurance.
Education and Expertise
Jean Philippe holds a Master 2 (M2) degree in Management de projet et innovation en biotechnologie from Université de Montpellier, which he completed from 2015 to 2017. He also earned a Licence de science de la vie pour l'ingénieur in Biotechnologie et Biologie générale from FGES, Faculté de gestion, économie et science, Lille, between 2012 and 2015. His educational background equips him with expertise in biotechnology and project management.
Professional Development
Throughout his career, Jean Philippe has focused on regulatory affairs within the biotechnology and medical device sectors. His experience spans various roles that emphasize compliance and quality assurance, contributing to his professional development in these fields. His educational qualifications further support his understanding of the complexities involved in regulatory processes.